Metraipolis › archive › dc_442991df67d0

Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42254455
DOI
10.1016/j.rpth.2026.106648
License (as archived)
solo-consultazione
Archived
2026-10-07T22:48:33.670Z
SHA-256 of the archived text
6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f
Stable URL of this page
https://metraipolis.com/documento/dc_442991df67d0

How to cite

Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455 — Europe PMC (en), https://europepmc.org/article/MED/42254455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_442991df67d0 (Metraipolis archive dc_442991df67d0, sha256 6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f)
BibTeX
@misc{dc442991df67d0,
  title = {Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42254455},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_442991df67d0; sha256 6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254455. Agents can read the archived copy with the MCP tool read_document.